Group 1 - The core viewpoint of the news is that He Eye Hospital has shown a slight increase in stock price and has low financing and margin trading balances, indicating a cautious market sentiment towards the company [1] Group 2 - As of January 22, He Eye Hospital's stock price increased by 0.47%, with a trading volume of 42.887 million yuan [1] - The financing buy-in amount on January 22 was 2.5777 million yuan, while the financing repayment was 2.1286 million yuan, resulting in a net financing buy-in of 0.4490 million yuan [1] - The total financing and margin trading balance for He Eye Hospital as of January 22 was 64.8946 million yuan, which is 1.91% of its circulating market value and below the 50th percentile level over the past year [1] Group 3 - As of September 30, the number of shareholders for He Eye Hospital was 9,888, a decrease of 8.55% from the previous period [2] - The average circulating shares per person increased by 60.07% to 12,301 shares [2] - For the period from January to September 2025, He Eye Hospital achieved an operating income of 855 million yuan, a year-on-year decrease of 1.11%, while the net profit attributable to the parent company was 54.3953 million yuan, a year-on-year increase of 232.18% [2] Group 4 - He Eye Hospital has distributed a total of 348 million yuan in dividends since its A-share listing, with 275 million yuan distributed over the past three years [3] - As of September 30, 2025, the top ten circulating shareholders included Rongtong Health Industry Flexible Allocation Mixed A/B (000727), holding 2.7015 million shares, a decrease of 93,200 shares from the previous period [3]

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 重要提示： 1.本次股东会无增加、变更、否决提案的情况。 2.本次股东会以现场与网络投票相结合的方式召开。 一、会议召开和出席情况 辽宁何氏眼科医院集团股份有限公司（以下简称"公司"）2026年第一次临时股东会于2026年1月14日召 开，公司董事会已于2025年12月25日在巨潮资讯网上刊登了《关于召开2026年第一次临时股东会的通 知》。 本次股东会由公司董事会召集，现场会议由公司董事长何伟先生主持，会议召开符合《公司法》《上市 公司股东会规则》《深圳证券交易所创业板股票上市规则》及《公司章程》等规定。 1.会议召开方式：本次股东会采用现场和网络投票相结合的方式召开。 2.会议召开日期和时间： 出席本次股东会的股东及其股东代表均为2026年1月7日（星期三）下午深圳证券交易所收市时，在中国 证券登记结算有限责任公司深圳分公司登记在册的公司普通股股东。 （1）股东出席的总体情况 通过现场和网络投票的股东84人，代表股份87,746,065股，占公司有表决权股份总 ...

Group 1 - The core viewpoint of the news is the performance and financial details of He Eye Hospital Group, which saw a stock price increase of 1.29% to 19.69 CNY per share, with a total market capitalization of 3.112 billion CNY [1] - He Eye Hospital Group, established on October 15, 2009, and listed on March 22, 2022, primarily provides specialized ophthalmic diagnosis and treatment services, with revenue breakdowns including 30.24% from vision services, 24.16% from refractive surgery, and 13.68% from cataract treatment [1] - The company reported a trading volume of 8.6667 million CNY and a turnover rate of 0.36% [1] Group 2 - Among the top ten circulating shareholders of He Eye Hospital, the Rongtong Health Industry Flexible Allocation Mixed A/B fund reduced its holdings by 93,200 shares, now holding 2.7015 million shares, which is 2.22% of the circulating shares [2] - The Rongtong Health Industry Flexible Allocation Mixed A/B fund, established on December 25, 2014, has a current scale of 1.816 billion CNY, with a year-to-date return of 8.73% and a one-year return of 6.27% [2] - The fund manager, Wan Minyuan, has a tenure of 9 years and 130 days, with the best fund return during this period being 131.32% [3]

Group 1 - The core viewpoint of the article is that Zhongyuan Securities has conducted a continuous supervision training for the management of Liaoning He Shi Eye Hospital Group Co., Ltd. to enhance their understanding of regulations related to fundraising and compliance [1][2] - The training took place on May 22, 2025, and was held both in-person and online, focusing on the key points of the "Regulations on the Supervision of Fundraising by Listed Companies" and other new rules [1] - Participants included directors, supervisors, senior management, and securities affairs representatives, indicating a comprehensive approach to compliance training [1][2] Group 2 - The training was well-received, with active participation from He Shi Eye Hospital and its attendees, which suggests a positive engagement with the training content [2] - The training aimed to strengthen the understanding of legal regulations regarding the use of raised funds, thereby enhancing the legal awareness and compliance consciousness of the management [2] - This initiative is expected to further improve the operational standards of He Shi Eye Hospital, indicating a commitment to regulatory compliance and governance [2]

本报记者 李勇 1995年，从一个百余平方米的小门诊开始，辽宁何氏眼科医院集团股份有限公司（以下简称"何氏眼 科"）秉承"科技人文"的经营理念，致力于让每一个人都可以拥抱光明的世界。目前，其已成长为一家 拥有百余家服务机构的知名眼科上市公司。 近日，《证券日报》记者来到何氏眼科，就公司的创新发展进行了采访。 从小诊所到知名眼科机构 何氏眼科的创立，源于公司创始人、董事长何伟博士"科技报国、科技惠民"的初心。 1987年，何伟被国家选派赴日本攻读医学博士学位，留学期间，何伟十余次回国义诊，见到了许多因病 致盲、又因盲致贫的患者。"我必须回到祖国，毫无保留地运用自身所学，为国家的防盲治盲事业贡献 微薄力量。"一次次的义诊经历让何伟感受到作为一名医者的责任与使命。 1995年，学成回国的何伟开启了创业之路，从125平方米的小眼科门诊开始，何氏眼科不断生根发芽， 发展壮大。 "刚涉足眼科时，我的愿望仅是做一名优秀的医生，后来发现个人的力量是微不足道的，我要开设一所 眼科医院。再后来，我进一步认识到，需要一个全方位的眼健康解决方案。"何伟向记者表示，从何氏 眼科创立之初，他就构想了一个集医、教、产、研于一体的眼健康生态 ...